Table 3.

Vitamin D related gene polymorphisms in male/female AD patients and controls.

Genotype	AD	Control	Crude OR	p	adjusted OR	pa
			(95% CI)		(95% CI)a
rs2282679A>C	AA/AC/CC
Male	145/99/21	110/107/30	0.719 (0.551-0.936)	0.014	0.725(0.555-0.947)	0.018
Female	196/180/35	135/143/26	0.922(0.730-1.163)	0.491	0.917(0.726-1.159)	0.469
rs10741657T>C	TT/TC/CC
Male	40/126/99	30/91/126	0.707 (0.549-0.911)	0.007	0.726(0.562-0.938)	0.014
Female	60/164/187	99/301/315	1.034 (0.836- 1.278)	0.759	1.027(0.830-1.271)	0.806
rs12785878T>G	TT/TG/GG
Male	54/128/83	58/117/72	1.108 (0.870-1.411)	0.406	1.101(0.862-1.405)	0.441
Female	80/207/124	69/154/81	1.148(0.929-1.420)	0.202	1.118(0.903-1.385)	0.306
rs6013897T>A	TT/TA/AA
Male	188/72/5	169/71/7	0.878 (0.628-1.228)	0.448	0.873 (0.622-1.224)	0.431
Female	471/205	201/96/7	0.953 (0.724-1.255)	0.733	0.957(0.726-1.262)	0.755

AD, Alzheimer's disease; OR, odds ratio; CI, confidence interval.

^aAdjusted for age.